167 related articles for article (PubMed ID: 29061446)
1. Increased proportion of a CD38
Ishioka-Takei E; Yoshimoto K; Suzuki K; Nishikawa A; Yasuoka H; Yamaoka K; Takeuchi T
Clin Immunol; 2018 Feb; 187():85-91. PubMed ID: 29061446
[TBL] [Abstract][Full Text] [Related]
2. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
3. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
5. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome.
Alunno A; Bistoni O; Carubbi F; Valentini V; Cafaro G; Bartoloni E; Giacomelli R; Gerli R
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):73-79. PubMed ID: 28664835
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjögren syndrome with and without lymphoma.
Johnsen SJ; Berget E; Jonsson MV; Helgeland L; Omdal R; Jonsson R
J Rheumatol; 2014 Nov; 41(11):2214-22. PubMed ID: 25274895
[TBL] [Abstract][Full Text] [Related]
10. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
[TBL] [Abstract][Full Text] [Related]
11. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome.
Bohnhorst JO; Thoen JE; Natvig JB; Thompson KM
Scand J Immunol; 2001 Oct; 54(4):421-7. PubMed ID: 11555410
[TBL] [Abstract][Full Text] [Related]
12. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
[TBL] [Abstract][Full Text] [Related]
13. The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution.
Szabó K; Jámbor I; Szántó A; Horváth IF; Tarr T; Nakken B; Szodoray P; Papp G
Front Immunol; 2021; 12():639975. PubMed ID: 33815392
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
16. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
18. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
Ter Borg EJ; Kelder JC
Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
[TBL] [Abstract][Full Text] [Related]
19. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
20. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
